Bridging the gap between academic IP and technology commercialization.


KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.

Latest News

11.04.21 - GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis...more

10.05.21 - GNS Healthcare Joins Memorial Sloan Kettering Innovation Hub for Precision Oncology...more

09.30.21 - A $150 million Return on Innovation...more

08.11.21 - Danimer Scientific Completes Acquisition of Biodegradable Polymer Producer Novomer...more

05.25.21 - GNS to Develop the World's First in silico Patient For Prostate Cancer...more


KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.227.8695

Fax: 1.607.257.1139